How Will the Transition to hs-cTn Affect the Diagnosis of Type 1 and 2 MI?
Expert Opinion | By Y Sandoval; FS Apple; AS Jaffe
Original Research | By S. Mohsen Hosseini, Raymond Kim, Sharmila Udupa
Clinical Trial | By Werner GS, Martin-Yuste V, EUROCTO trial investigators.
Clinical Trial | By SR Steinhubl, J Waalen, AM Edwards et al.
Clinical Trial | By Chen L, Xu T, Chen SL et al.
Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies
Review Article | By Tajti P, Brilakis ES.
Original Research | By DA Jones, KS Rathod, S Koganti et al.
Clinical Trial | By Bourantas CV, Ramasamy A, Karagiannis A et al.
Clinical Trial | By Stone PH, Saito S, PREDICTION Investigators.
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization
Original Research | By Head SJ, Milojevic M, Daemen J et al.